ADGM Stock Catalyst: Adagio Medical Announces FULCRUM-VT Study Results Presentation

Sep 17, 2025 · 6:44pm ET

Results to be presented at the 0th Annual International Symposium on Ventricular Arrhythmias.

Max move

+72.4%

High of day $2.50

Sparker timei

6:44pm ET

ADGM · Sep 17, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Adagio Medical Holdings, Inc. (ADGM) announced that results from its FULCRUM-VT U.S. pivotal study will be presented at a late-breaking session at the 0th Annual International Symposium on Ventricular Arrhythmias, scheduled for October 10-11.

The FULCRUM-VT study is a significant trial evaluating the company's cryoablation technology for treating ventricular tachycardia. The presentation will provide detailed insights into the study's outcomes.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time ADGM sparks.

Download Sniper App →

Catch the next ADGM-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →